Page 69
conferenceseries
.com
Volume 4
Endocrinology & Diabetes Research
October 01-02, 2018 Osaka, Japan
12
th
International Conference on
Endocrinology, Diabetes and Metabolism
Endocrinology Summit 2018
October 01-02, 2018
Illness Perceptions and Hemoglobin A1c among Type 2 Diabetes patients
Li-Yun Lee and Yu-Ju Yu
CMUB Hospital, Taiwan
Aim:
Diabetes is a chronic , potentially life-threatening illness which affects many aspects of an individual’s life. This study
explored Illness Perception and Hemoglobin A1c in type 2 Diabetes patients.
Methods:
Researchwas conducted using a cross-sectional study. Patients (n=99) were recruited from the outpatient department
of a metabolism clinic in a teaching hospital in southern Taiwan. Eligible subjects assessed using the Illness Perception
Questionnaires (IPQ-R), Hemoglobin A1c (HbA1c) testing and background Information Form. Stepwise regression was
applied to explore the predictors of Hemoglobin A1c percentage. The data analysis was conducted with descriptive statistics,
t-test, chi-square and linear regression. All calculations were made using SPSS for Windows, version 20.0(Chicago, IL, USA).
Results:
Among the Ninety-nine type 2 Diabetes patients participated in this study. The results showed that patients had 54
male and 45 females, mean age was 60.36years, had 35 smokers and 64 non-smokers, meals prepare by Self was 37.4%, Exercise
habit over 90 minitues per week was 30.3%, HbA1c percentage was 8.08%. The Body mass index and the illness perception -
Timeline cyclical subscale scores were the most significance factors in HbA1c percentage.
Conclusions:
Type 2 Diabetes patients experienced illness perceptions. Body mass index and Timeline cyclical affect HbA1c
percentage. Illness perceptions changes can impact on glycaemic control.
Implications for Practice:
Study findings can provide of illness perceptions in eastern population. Future research may further
intervention to improve the illness perceptions and HbA1c percentage control of the disease.
leeliyun0325@yahoo.com.twEndocrinol Diabetes Res 2018, Volume 4
DOI: 10.4172/2470-7570-C3-015